Wednesday, 2 May 2018

Point-of-care Diagnostics Market Value to Reach US$ 11.7 Billion by 2024

The global point-of-care diagnostics market is prognosticated to witness a notable growth during the forecast period from 2016 to 2024. The market is highly consolidated and the main four players held an astounding market share of 78.8% in the year 2015. These players are Abbott Inc., F. Hoffmann-La Roche Ltd., Alere Inc., and Becton Dickinson and Co. These firms lead the global point-of-care market by always improving their product portfolio and are putting in constant efforts to create advanced and innovative offerings. Focusing on building technologically advanced product is a key technique adopted by various market players, in order to take their shares to higher position and to sustain and improve their position in the global market. Some of the leading players are working on tapping the upcoming opportunities by extending their business to developing regions of Asia Pacific, Latin America, and Africa. The under-tapped medical needs in these regions presents a major growth opportunity to different market players.


According to Transparency Market Research the global point-of-care diagnostics market is estimated to project a decent growth in coming years by registering a steady CAGR of 6.9% within 2016 to 2024. The market was estimated to be of worth US$6.8bn in year 2016, which is anticipated to soar to a value of US$11.7 bn by the end of 2024. Based on application, the global market of point-of-care diagnostics is led by infectious disease testing segment. The increased cases of swine flu, HIV/AIDS, and Ebola will boost the segment in coming years as well.

The increasing rate of several chronic and interminable ailments and lifestyle-related illness such as diabetes and hypertension, and the rising predominance of different tumors and cardiovascular diseases (CVD) in different developed and developing nations are key factors driving the market. An increased number of geriatric population in these regions require fast testing of various illness at home settings and this is strengthening the demand for point-of-care systems. Moreover, the increased adoption of this type of testing to supplement a compressive checking of sicknesses is boosting the market.


The escalating demand for diagnostic units for better maternity wellbeing in various developing economies is likewise supporting the demand for point-of-care testing, globally. Moreover, the squeezing requirement for point-of-care testing modules for the location of tumor biomarkers is accelerating the development of the market.

The danger of misdiagnosis in point-of-care testing in the absence of reliable screening procedures for numerous ailments and the need to get precise outcomes have led to the popularity of lab testing facilities in different regions. This is one factor hampering the interest for point-of-care testing to a certain degree.

Serving to offset the drawback is the emergence of lateral flow assay to enable clinicians to analyze an extensive variety of biological samples by testing various parameters just in one strip. This is highlighting the development of the market over the forecast period. For example, the use of point-of-care testing for a minimally invasive technique of different tumor biomarkers is an appreciated innovation helping the development of the market.


About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

No comments:

Post a Comment